Kevin Bitterman, | Board Member | Editas Medicine

Skip to main navigation

Newsroom
Get in Touch
LinkedIn

Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors

Newsroom
Get in Touch
LinkedIn

Media & Investors

Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
Investor FAQs
Contact

Biography

Kevin Bitterman, Ph.D.

Director

Independent Director

>> Main navigation

Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors

©Copyright 2026 Editas Medicine

>> Footer menu

Get in Touch
Investors
Privacy Policy
Terms of Use